NCT04495647

Brief Summary

Exercise in general and resistance training (RT) in particular have demonstrated positive effects on physical functioning and frailty. However, frail older people with functional impairments are among the least physically active and may have problems reaching high intensity levels. The use of special vests with integrated electrodes allows the simultaneous innervation of all large muscle groups by external electrical stimulation, inducing a high-intensity RT at low subjective effort level. This whole-body electromyostimulation (WB-EMS) may be a feasible option inducing training stimuli for functionally impaired frail older people. This study aims at investigating the feasibility and safety of WB-EMS in frail older people with functional limitations. To explore the effects of age and functional status, young and robust old reference groups will serve as comparators.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2020

Completed
12 days until next milestone

Study Start

First participant enrolled

July 22, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 3, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
Last Updated

April 28, 2021

Status Verified

April 1, 2021

Enrollment Period

5 months

First QC Date

July 10, 2020

Last Update Submit

April 27, 2021

Conditions

Outcome Measures

Primary Outcomes (9)

  • Recruitment rate

    measured by ratio of included/eligible participants

    8 weeks

  • Compliance

    measured by proportion of attended training sessions

    from baseline to 8 weeks

  • Retention rate

    measured by proportion of participants remaining in the study

    at 8 weeks

  • Dropout rate

    measured by the proportion of participants not completing the study

    from baseline to 8 weeks

  • Perceived enjoyment measured by the Physical Activity Enjoyment Scale for Older Adults (PACES-8)

    The PACES-8 comprises of 8 items on a 7-point bipolar rating scale. A sum score is calculated with higher PACES scores reflecting greater levels of enjoyment.

    Change from baseline to 8 weeks

  • Intervention engagement measured by the Hopkins Rehabilitation Engagement Scale (HRERS)

    The HRERS, reported by instructors, comprises of 5 items on a verbal rating scale from 'Never' to 'Always'. Higher scores reflect greater levels of engagement.

    at 8 weeks

  • Concentration of Myoglobin (MB)

    Concentration of MB measured in µg/l 3 hours after training

    measured at baseline to week 1, week 3 and week 8

  • Concentration of Creatinkinase (CK)

    Concentration of CK measured in U/l before, 48, 72 hours after training

    measured at baseline to week 1, week 3 and week 8

  • estimated glomerular filtration rate (eGFR)

    eGFR (creatinine clearance) measured in mL/min/1.73m² before, 48, 72 hours after training

    measured at baseline to week 1, week 3 and week 8

Secondary Outcomes (17)

  • Rhabdomyolysis surveillance measured by a self-developed questionnaire

    measured weekly

  • Pain assessed by the Brief Pain Inventory (BPI-SF)

    measured at baseline to week 1, week 3 and week 8

  • Fatigue assessed by the Brief Fatigue Inventory (BFI)

    measured at baseline to week 1, week 3 and week 8

  • System usability measured by the System Usability Scale (SUS)

    once at 8 weeks

  • Lower extremity functioning measured by the Short Physical Performance Battery (SPPB)

    Change from baseline to 9 weeks

  • +12 more secondary outcomes

Other Outcomes (11)

  • Health-related quality of life measured by the patient-reported Health Survey Short Form (SF-12)

    Change from baseline to 9 weeks

  • Concentration of Interleukin 6 (IL-6)

    measured at baseline to week 1, week 3 and week 8

  • Concentration of High-sensitivity C-reactive protein (hs CRP)

    measured at baseline to week 1, week 3 and week 8

  • +8 more other outcomes

Study Arms (3)

WB-EMS_frail

EXPERIMENTAL
Other: Whole-Body Electromyostimulation

WB-EMS_robust

ACTIVE COMPARATOR
Other: Whole-Body Electromyostimulation

WB-EMS_young

ACTIVE COMPARATOR
Other: Whole-Body Electromyostimulation

Interventions

Whole-Body Electromyostimulation (WB-EMS): Simultaneous, individually adjustable stimulation of 12 muscle groups using an interval approach with a duty cycle of 6s impulse/4s rest, bipolar electric current (impulse -frequency 85Hz, -width 350μs, rectangular pattern) will be applied. After a 4-week conditioning period, 1.5x 20 min/week WB-EMS will be conducted for 4 weeks (total training duration 8 weeks). Easy to perform functional exercises focusing on balance, transfer ability, stepping and lower extremity strength/power will be done during WB-EMS. Exercise intensity will be individually prescribed and adjusted by rate of perceived exertion (RPE-Borg CR10 scale 4 (moderate) to 7 (hard)). WB-EMS will be fully supervised one on one. All three arms will receive the same intervention.

WB-EMS_frailWB-EMS_robustWB-EMS_young

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • + years
  • Frail
  • able to walk 4m w/o walking aid
  • no prior WB-EMS exposure

You may not qualify if:

  • severe visual or hearing impairments
  • major cognitive impairment (MMSE \<10)
  • medications with muscle-anabolic effects
  • medical conditions affecting trainability of muscles (e.g. Myasthenia gravis, Cushing syndrome, Morbus McArdle)
  • surgery within past two months
  • history of rhabdomyolysis
  • medical conditions affecting sensation of electrical stimuli (e.g. severe polyneuropathy)
  • severe renal insufficiency (eGFR\<30 ml/min/1.73m²)
  • electronic implants
  • acute or untreated abdominal wall or inguinal hernia
  • Robust people
  • + years
  • Robust
  • no prior WB-EMS exposure
  • severe visual or hearing impairments
  • +24 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Medical Physics, University of Erlangen-Nürnberg

Erlangen, 91052, Germany

Location

MeSH Terms

Conditions

FrailtyMobility Limitation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: frail older people (n=10) pre-post; robust older (n=10) and young (n=10) reference groups with identical intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2020

First Posted

August 3, 2020

Study Start

July 22, 2020

Primary Completion

December 31, 2020

Study Completion

February 28, 2021

Last Updated

April 28, 2021

Record last verified: 2021-04

Locations